Why Zoetis Is the Pfizer of Animal Healthcare

Zoetis (NYSE:ZTS) is a leader in the pharmaceutical market for pets and livestock. It used to be a part of Pfizer (NYSE:PFE), but was spun off in 2012.

What makes Zoetis's business attractive is the depth and breadth of its offerings, which include vaccines, anti-infectives, and parasiticides, serving a diverse array of pet and livestock species. This wide-ranging portfolio of blockbuster drugs is built along much the same lines as that of its former parent company, Pfizer.